Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
BeiGene to Present at Upcoming Investor Conferences
-
Bragar Eagel & Squire, P.C. Is Investigating Castle, Coinbase, Arrival, and BeiGene and Encourages Investors to Contact the Firm
-
BeiGene to Present at Upcoming Investor Conferences
-
BeiGene, Ltd. (BGNE) PT Raised to $262 at Cowen
-
BeiGene to Present at Cowen’s 43rd Annual Healthcare Conference
-
BeiGene to Present at Upcoming Investor Conferences
-
BeiGene to Present at the Cowen 42nd Annual Health Care Virtual Conference
-
BeiGene (BGNE) Not on Updated Entity List From US Dept of Commerce - Cowen
-
BeiGene, Ltd. (BGNE) PT Lowered to $427 at Cowen
-
BeiGene, Ltd. (BGNE) PT Raised to $429 at Cowen
-
BeiGene to Present at the Cowen and Company’s 40th Annual Health Care Conference
-
BeiGene, Ltd. (BGNE) PT Lowered to $216 at Cowen, Following Drug Trial Results
-
BeiGene to Present at Upcoming Investor Conferences
-
Cowen Starts BeiGene, Ltd. (BGNE) at Outperform
-
BeiGene to Present at Upcoming Investor Conferences
-
BeiGene Announces Closing of $800 Million Public Offering
-
BeiGene (BGNE) Prices 7.426M ADS Offering at $101/Sh
-
BeiGene Announces Pricing of $750 Million Public Offering
-
BeiGene (BGNE) Plans $650M Offering of ADSs
-
BeiGene Announces Proposed Public Offering
-
BeiGene (BGNE) Prices of 2.47M Public Offering at $71/ADS
-
BeiGene Announces Pricing of $175 Million Public Offering
-
BeiGene (BGNE) to Offer and Sell $125M ADSs
-
BeiGene Announces Proposed Public Offering
-
BeiGene to Present at the Cowen and Company 37th Annual Health Care Conference
-
BeiGene Announces Closing of $200 Million Public Offering
-
BeiGene (BGNE) Prices 6.25M ADS Follow-on Offering for Proceeds of $200M
-
BeiGene Announces Pricing of $200 Million Public Offering
-
BeiGene Announces Proposed Public Offering
-
BeiGene to Present at Cowen and Company 36th Annual Health Care Conference
-
Cowen Starts BeiGene, Ltd. (BGNE) at Outperform
-
BeiGene Announces Closing of Its Initial Public Offering
-
BeiGene (BGNE) IPO Opens Up 20%
-
BeiGene Announces Pricing of Its Initial Public Offering

